United States· US:0472-1030_7937f983-1f1c-475b-ab10-76a582d1bedd
Hydromet
A medicinal product containing hydrocodone bitartrate; homatropine methylbromide, registered in United States by Actavis Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYDROCODONE BITARTRATE; HOMATROPINE METHYLBROMIDE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 30, 2026
Packs & prices · 2
- ndc110472103016473 mL in 1 BOTTLE (0472-1030-16)
- ndc110472-1030-16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b1f73a8-36d1-4d51-9405-b27b6010ab09 GET /v1/drugs/7b1f73a8-36d1-4d51-9405-b27b6010ab09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5; 1.5",
"substance": "HYDROCODONE BITARTRATE; HOMATROPINE METHYLBROMIDE",
"productndc": "0472-1030",
"dosage_form": "SOLUTION",
"dea_schedule": "CII",
"strength_unit": "mg/5mL; mg/5mL",
"application_number": "ANDA088017",
"marketing_category": "ANDA"
}See everything about hydrocodone bitartrate; homatropine methylbromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.